PeptideDB

2-Bromohexadecanoic acid (2-Bromopalmitic acid) 18263-25-7

2-Bromohexadecanoic acid (2-Bromopalmitic acid) 18263-25-7

CAS No.: 18263-25-7

2-Bromohexadecanoic acid (2-Bromopalmitic acid) is a 2-bromopalmitic acid that can be converted to 2-bromopalmitate (2-B
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

2-Bromohexadecanoic acid (2-Bromopalmitic acid) is a 2-bromopalmitic acid that can be converted to 2-bromopalmitate (2-BP). 2-BP is a palmitoylation inhibitor that targets the DHHC (Asp-His-His-Cys) protein palmitoyltransferase. 2-BP inhibits the palmitoylation of GSDME-C and inhibits pyroptosis mediated by the BAK/BAX-Caspase 3-GSDME pathway.

Physicochemical Properties


Molecular Formula C16H31BRO2
Molecular Weight 335.32
Exact Mass 334.15
Elemental Analysis C, 57.31; H, 9.32; Br, 23.83; O, 9.54
CAS # 18263-25-7
PubChem CID 82145
Appearance White to yellow solid
Density 1.1±0.1 g/cm3
Boiling Point 403.4±18.0 °C at 760 mmHg
Melting Point 52-54 °C
Flash Point 197.8±21.2 °C
Vapour Pressure 0.0±2.0 mmHg at 25°C
Index of Refraction 1.480
LogP 7.76
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 2
Rotatable Bond Count 14
Heavy Atom Count 19
Complexity 207
Defined Atom Stereocenter Count 0
SMILES

CCCCCCCCCCCCCCC(C(=O)O)Br

InChi Key DPRAYRYQQAXQPE-UHFFFAOYSA-N
InChi Code

InChI=1S/C16H31BrO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(17)16(18)19/h15H,2-14H2,1H3,(H,18,19)
Chemical Name

2-bromohexadecanoic acid
Synonyms

2-bromopalmitate; 2-BP; 2-Bromopalmitate; 2BP; 2-Bromopalmitic acid; 2 BP; 2 Bromopalmitate; 2Bromopalmitate; 2Bromopalmitic acid; 2 Bromopalmitic acid;
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro After GSDME-N is cleaved, palmitoylation encourages the release of GSDME-C, whereas 2-BP prevents palmitoylation, prevents GSDME-C from being modified, and increases the interaction between GSDME-C and GSDME-N. 2-BP prevents apoptosis brought on by TNFa+CHX, but not complete cell death [1].
Cell Assay For navitoclax or TNFα+CHX treatments, cells were pre-seeded overnight until cell density reached ~60%. The culture medium was switched to fresh medium containing relevant drugs and incubated for a period of time as indicated. To inhibit caspase activity or palmitoylation, cells were pre-incubated for 1 h with Q-VD-OPh or 2-BP, respectively. Unless otherwise specified, the concentrations of the drugs used are: 2 μM for navitoclax, 20 ng/mL for TNFα, 10 μg/mL for CHX, 50 μM for Q-VD-OPh, 50 μM for 2-BP, and 50 μM for actinomycin D [1].
References

[1]. Chemotherapy-induced pyroptosis is mediated by BAK/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate. Cell Death Dis. 2020 Apr 24;11(4):281.

Additional Infomation 2-bromohexadecanoic acid is a bromo fatty acid that is hexadecanoic (palmitic) acid carrying a single bromo substituent at position 2. It has a role as a fatty acid oxidation inhibitor. It is a bromo fatty acid, a straight-chain fatty acid, a long-chain fatty acid and a 2-bromocarboxylic acid. It is functionally related to a hexadecanoic acid.

Solubility Data


Solubility (In Vitro) DMSO : 100 mg/mL (298.22 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (7.46 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (7.46 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.9822 mL 14.9111 mL 29.8223 mL
5 mM 0.5964 mL 2.9822 mL 5.9645 mL
10 mM 0.2982 mL 1.4911 mL 2.9822 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.